A bill for an act relating to the dispensing of hydroxychloroquine and ivermectin through a standing order in the state.
Impact
One of the bill's notable provisions is the immunity granted to pharmacists and the medical director of the department of public health from both civil and criminal liability related to the dispensing of hydroxychloroquine and ivermectin as per the established standing order. This aspect is crucial as it reduces the risk for pharmacists in providing these medications, thereby encouraging them to dispense them as outlined in the bill. This change in state law could potentially increase access to these drugs in Iowa, amidst significant public discussions regarding their effectiveness in treating various conditions.
Summary
House File 2056 aims to authorize the dispensing of hydroxychloroquine and ivermectin by pharmacists through a standing order established by the state's medical director. This bill stipulates that pharmacists can provide these medications to patients aged 18 and older, upon patient request, without the need for a prior prescription from a doctor or an appointment. The requirement for pharmacists includes providing patients with the manufacturer's instructions when dispensing these drugs, ensuring patients are informed about their usage.
Contention
The bill has sparked debate due to the controversial nature of hydroxychloroquine and ivermectin, particularly concerning their efficacy against diseases like COVID-19. Critics argue that allowing pharmacists to dispense these medications without a prescription may lead to misuse and could undermine public health measures aimed at ensuring appropriate medical oversight. Supporters of the bill, however, contend that it will streamline access to these drugs for patients who believe they may benefit from them, particularly given the ongoing discussions about therapeutic options during public health emergencies.
Authorize the dispensing of ivermectin and hydroxychloroquine under a written protocol developed by a health care provider, and to provide liability protection therefor.
Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.
Authorize the dispensing of ivermectin and hydroxychloroquine under a written protocol developed by a health care provider, and to provide liability protection therefor.
Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.